The influence of age on the psychological profile of patients with cardiac implantable electronic devices: results from the Italian population in a multicenter study conducted by the European Heart Rhythm Association-Reference-Cited by-同舟云学术

The influence of age on the psychological profile of patients with cardiac implantable electronic devices: results from the Italian population in a multicenter study conducted by the European Heart Rhythm Association

Published:2018-12-14 Issue:9 Volume:31 Page:1219-1226
ISSN:1720-8319
Container-title:Aging Clinical and Experimental Research
language:en
Short-container-title:Aging Clin Exp Res

Author:

Fumagalli Stefano^ORCID,Pieragnoli Paolo,Haugaa Kristina H.,Potpara Tatjana S.,Rasero Laura,Ramacciati Nicola,Ricciardi Giuseppe,Solimene Francesco,Mascia Giuseppe,Mascioli Giosuè,Zuo Giulia,Roberts Anna T.,Marchionni Niccolò,Lenarczyk Radoslaw,Boveda Serge,Dagres Nikolaos

Publisher

Springer Science and Business Media LLC

Subject

Geriatrics and Gerontology,Ageing

Link

http://link.springer.com/content/pdf/10.1007/s40520-018-1088-5.pdf

Reference23 articles.

1. European Society of Cardiology (ESC), European Heart Rhythm Association (EHRA), Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 15:1070–1118. https://doi.org/10.1093/europace/eut206

2. Fumagalli S, Valsecchi S, Boriani G et al (2011) Comparison of the usefulness of cardiac resynchronization therapy in three age-groups (< 65, 65–74 and ≥ 75 Years) (from the InSync/InSync ICD Italian Registry). Am J Cardiol 107:1510–1516. https://doi.org/10.1016/j.amjcard.2011.01.031

3. Fumagalli S, Gasparini M, Landolina M et al (2014) Determinants of all-cause mortality in different age groups in patients with severe systolic left ventricular dysfunction receiving an implantable cardioverter defibrillator (from the Italian ClinicalService Multicenter Observational Project). Am J Cardiol 113:1691–1696. https://doi.org/10.1016/j.amjcard.2014.02.025

4. Padeletti L, Arnar DO, Boncinelli L et al (2010) EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace 12:1480–1489. https://doi.org/10.1093/europace/euq275

5. Cattorini P, Marchionni N (1994) Clinical decision-making and the “treat or not to treat” dilemma in geriatrics: ethical implications. Aging (Milano) 6:391–398

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Optimal Cardiac Resynchronization Therapy with Conduction System Pacing Guided by Electro-Anatomical Mapping: A Case Report;Journal of Cardiovascular Development and Disease;2023-11-09

3. One-Year Mortality in Patients Undergoing an Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy Pulse Generator Replacement: Identifying Patients at Risk;Journal of Clinical Medicine;2023-08-30

4. Long-Term Outcomes of Transvenous Lead Extraction: A Comparison in Patients with or without Infection from the Italian Region with the Oldest Population;Journal of Clinical Medicine;2023-07-07

5. Moderator Band and Ventricular Tachycardia: Structural or Functional Substrate?;Journal of Cardiovascular Development and Disease;2023-04-06